PAM
MDGL icon

Princeton Alpha Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Princeton Alpha Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-407
Closed -$43K – 780
2014
Q3 		$43K Buy
+407
New +$56.6K 0.01% 628

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Princeton Alpha Management's MDGL Position: Q4 2014 in Review

Princeton Alpha Management sold out of Madrigal Pharmaceuticals (MDGL) in Q4 2014, closing a stake of 407 shares — an estimated $43K sold.

Princeton Alpha Management first reported a position in MDGL in Q3 2014 and held it in 1 quarter. The position peaked at $43K in Q3 2014. 84 funds tracked by Wall St. Rank hold MDGL as of Q4 2014.

  • Princeton Alpha Management reported no remaining Madrigal Pharmaceuticals position as of Q4 2014 after selling out during the quarter.
  • Princeton Alpha Management sold 407 Madrigal Pharmaceuticals shares in Q4 2014, an estimated $43K.
  • Princeton Alpha Management first reported a position in Madrigal Pharmaceuticals in Q3 2014 and held it in 1 quarter.
  • Princeton Alpha Management's Madrigal Pharmaceuticals position peaked at $43K in Q3 2014.
  • 84 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q4 2014.

Based on Princeton Alpha Management's 13F filing for Q4 2014, filed 6 Feb 2015.